Novel dual GIP and GLP-1 receptor agonist showed promising results for both reduction in A1C and weight loss. 

How safe and effective is the first commercial configuration of a tubeless automated insulin delivery system in children and adults with type 1 diabetes? 

Study examines the complex relationship between type 2 diabetes, metformin use, and breast cancer subtype.

Researchers sought to assess the prevalence and trend of diabetic complications in adult patients over thirty years.

Clinical dietitians and mobile apps play a crucial role in personalizing treatment for patients with gestational diabetes.

Lifestyle management and intervention alongside a once-weekly semaglutide dose of 2.4 mg. can lead to improved weight loss for patients with overweight or obesity.  

Can specific risk markers be identified for onset and early progression of diabetic retinopathy in people with type 1 diabetes?

Type 1 diabetes mellitus patients with high BMI and hypoglycemia may improve quality of life through dapagliflozin treatment. 

A combined pharmacological therapy showed efficacy in bodyweight reduction without lifestyle, diet, physical activity changes or surgery.

Patients with diabetes and COVID-19 were more likely to die within 14 days of hospitalization than those without diabetes.